Daily Bulletin

Men's Weekly

.

FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

IND approved to trial PXS-5505 added to current standard of care in newly diagnosed unresectable hepatocellular carcinoma patients

University of Rochester Medical Center and Pharmaxis in discussions to commence investigator-led study in 2022

SYDNEY, Nov. 9, 2021 /PRNewswire/ -- Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today...

Read more: FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer

Business News

Car Rental as a Practical and Flexible Solution for Travel or Work

The contemporary, hectic way of life is one of ease and adaptability while commuting and working. Regardless of whether one moves around by road, commuting between towns for conferences, or taking a f...

Daily Bulletin - avatar Daily Bulletin

Car Park Markings Melbourne: How Quality Line Marking Shapes Safer Spaces

In modern busy urbanized societies, structured parking areas are necessary in terms of both security and convenience. At a shopping center, business establishment, or a publicly-accessible facility, t...

Daily Bulletin - avatar Daily Bulletin

Cleaning Australia: The Rise of Professional Cleaning Services

The cleaning industry in Australia is booming as more people are opting for professional cleaning services to keep their homes, offices, and businesses spotless. With the increasing demand for cleanli...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business